概括
在血液透析患者中,个性化冷却透析剂没有减少心血管事件. 这项研究对冷却透析剂的广泛采用提出了质疑,表明需要对特定患者群体进行进一步研究.
科学领域:
- 肝脏病学
- 心血管医学
- 临床试验
背景情况:
- 血液透析通常使用36. 5°C的标准透析剂温度.
- 降温透析剂 (≤36. 0°C) 越来越多地用于潜在的心血管益处.
- 个性化冷却器透析剂作为中心范围的政策的有效性需要调查.
研究的目的:
- 与标准温度透析剂相比,评估个性化冷却透析剂是否可以减少心血管死亡或住院.
- 评估整个中心对维护血液透析中的个性化冷却透析剂的政策的影响.
主要方法:
- 在加拿大安大略省的84个血液透析中心进行实用性,随机集群优势试验.
- 个性化冷却透析剂 (0. 5- 0. 9°C低于患者体温,min 35. 5°C) 或标准 36. 5°C透析剂.
- 主要结局是4年内心血管死亡或心肌梗塞,缺血性中风或心力衰竭的住院.
主要成果:
- 在冷却透析剂 (21. 4%) 和标准温度组 (22. 4%) 的初级复合结果中没有显著差异 (aHR 1. 00; 96% CI 0. 891. 11; p=0. 93).
- 透析液的平均温度为35. 8°C (较冷) 和36. 4°C (标准).
- 两组之间没有显著的平均静脉血压下降.
结论:
- 全中心实施个性化冷却透析剂并没有显著减少重大心血管事件.
- 这项研究挑战了目前采用冷却透析剂的趋势,
- 未来的试验应该澄清冷透析剂在特定患者群体中的风险和益处.
相关概念视频
01:25Hemodialysis III: Nursing Management
128
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
128
01:15Dialysis
769
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
769
01:24Hemodialysis II: Procedure and Complications
96
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
96
01:25Hemodialysis I: Introduction
197
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
197
01:25Peritoneal Dialysis III: Nursing Management
100
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
100
01:30Peritoneal Dialysis I: Introduction and Procedure
123
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
123